Posted on 2/12/18
Oncobiologics Announces Term Extension of Series A Warrants
CRANBURY, N.J., Feb. 09, 2018 (GLOBE NEWSWIRE) -- Oncobiologics, Inc. (NASDAQ:ONS) (NASDAQ:ONSIW) (NASDAQ:ONSIZ) announced today an extension to the term for exercise of its publicly traded . . .
Posted on 2/12/18
Chembio Diagnostics Prices Public Offering of Common Stock
MEDFORD, N.Y., Feb. 09, 2018 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (NASDAQ:CEMI), a leader in point-of-care diagnostic tests for infectious diseases, announced today the pricing of . . .
Posted on 2/11/18
Celgene Prices $4.5 Billion of Senior Unsecured Notes
SUMMIT, N.J.--(BUSINESS WIRE)--Celgene Corporation (NASDAQ:CELG) today announced the successful pricing of four series of senior unsecured notes for an aggregate principal amount of $4.5 billion. Of . . .
Posted on 2/8/18
Astor Services Partners with NYS Department of Health and Others In Support of Youth Home Care Initiative
Effort Involves Launch of Child Adolescent Needs and Strengths–NY (CANS–NY) Training & Technical Assistance InstituteAstor Services for Children & Families, which provides behavioral and educational services . . .
Posted on 2/8/18
Johnson & Johnson: Waiting For A Better Yield
Johnson & Johnson's dividend yield has gradually been getting less competitive relative to its peers.While the company is still strong, competition in the pharmaceutical sector as . . .
Posted on 2/7/18
Retro Fitness Named Official Fitness Center of New York Yankees
Just in time for the start of baseball season, Retro Fitness is now the Official Fitness Center of the New York Yankees. In this multi-year partnership, . . .
Posted on 2/7/18
3 Megacompanies Want to Shake Up Healthcare
When it comes to sky-high healthcare costs, Amazon.com (NASDAQ:AMZN), Berkshire Hathaway (NYSE:BRK-A)(NYSE:BRK-B), and JPMorgan Chase (NYSE:JPM) have had enough. The three companies are creating a new . . .
Posted on 2/6/18
CBD For Life Recognized By Hollywood Beauty Awards As Product Of The Year - Skincare Award Winner
CBD For Life announced today that its highly innovative, natural and effective Cannabidiol (CBD) infused pain management and beauty products will receive the Product of the . . .
Posted on 2/6/18
Extend Fertility Medical Practice Adds Bat-Sheva Lerner Maslow to its World-Class Staff of Physicians
Extend Fertility Medical Practice, a one-of-a-kind, specialty egg-freezing practice in Manhattan, today announced the hiring of reproductive endocrinologist Bat-Sheva Lerner Maslow, MD, MSCTR, FACOG. Dr. Maslow . . .
Posted on 2/6/18
3 Things to Really Like About Bristol-Myers Squibb's Q4 Earnings Results
When Bristol-Myers Squibb (NYSE:BMY) reported its third-quarter earnings results in October, some investors might have wondered if they needed to worry. The big pharma company posted . . .
Posted on 2/5/18
Sensus Healthcare Launches Collaboration with BirchBioMed
Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT), announced . . .
Posted on 2/5/18
Merck Company Inc. (MRK) Q4 2017 Earnings Conference Call Transcript
IMAGE SOURCE: THE MOTLEY FOOL.Merck & Company, Inc. (NYSE:MRK)Q4 2017 Earnings Conference CallFeb. 2, 2018, 8:00 a.m. ETContents:Prepared RemarksQuestions and AnswersCall ParticipantsPrepared Remarks:OperatorGood morning. My name . . .
Posted on 2/5/18
Where's Honeywell Headed In 2018?
Source: Honeywell Company ImageAmerican multinational conglomerate Honeywell (HON) had a great year in 2017. HON's stock price rose 32% outpacing peers United Technologies (UTX) and General . . .
Posted on 2/5/18
Honeywell Does It Again
Image creditHoneywell (HON) has been and continues to be my favorite industrial stock. The company’s ability to constantly improve not only revenue but margins as well . . .
Posted on 2/5/18
Merck: Keytruda Remains Key
Merck (MRK) has done relatively well since the last time I checked on the prospects for the shares (being the end of October) as they traded . . .
Posted on 2/5/18
Here's What Pfizer's Saying About Its Future
Pfizer Inc.'s (NYSE:PFE) fourth-quarter and full-year 2017 financial results suggest it's on its way toward becoming a growth stock again, and on its quarterly conference call, . . .
Posted on 2/4/18
Celgene Corp. Commences Tender Offer for Juno Therapeutics
SUMMIT, N.J.--(BUSINESS WIRE)--Celgene Corporation (NASDAQ:CELG) today announced that its wholly-owned subsidiary, Blue Magpie Corporation, has commenced its previously announced tender offer for all outstanding shares of . . .
Posted on 2/2/18
Johnson & Johnson Or Pfizer For Dividends?
As the market continues to roar higher, the search for strong dividend yields for retirement portfolios becomes much tougher. But do we really need a 3% . . .
Posted on 2/2/18
Actinium Pharmaceuticals Announces Rights Offering
NEW YORK, Feb. 01, 2018 (GLOBE NEWSWIRE) -- Actinium Pharmaceuticals, Inc. (NYSE American:ATNM) announced today that it has filed a preliminary prospectus supplement as a part . . .
Posted on 2/1/18
Honeywell: The Stock Will Fly Higher In 2018
Honeywell (HON) is a must own stock in today's environment. The company recently reported better-than-expected Q4 2017 results, and management also raised their fiscal 2018 guidance . . .
Posted on 2/1/18
Is Celldex Therapeutics, Inc. (CLDX) a Buy?
Many biotech stocks posted strong performances in 2017. Celldex Therapeutics(NASDAQ:CLDX) wasn't one of them. The clinical-stage biotech saw its share price drop 20% last year. And . . .
Posted on 1/31/18
Johnson & Johnson to Participate in the Leerink Partners 7th Annual Global Healthcare Conference
Johnson & Johnson (NYSE: JNJ) will participate in the Leerink Partners 7th Annual Global Healthcare Conference on Wednesday, Feb. 14, at Lotte New York Palace, NY. . . .
Posted on 1/31/18
Medidata and Syapse Announce Partnership
Medidata (NASDAQ: MDSO), the leading global provider of cloud-based technology and data analytics for clinical research, and Syapse, a market leader in precision medicine solutions, have . . .
Posted on 1/31/18
Advarra And TransPerfect Form Strategic Language Services Partnership
TransPerfect Life Sciences, a leading provider of technologies and services to support clinical trials and product development for the biopharmaceutical industry, today announced that it has . . .
Posted on 1/31/18
Pfizer's Q4: Should Investors Buy The Dip?
Many consumers are familiar with the products of healthcare giant Pfizer (PFE), the business that is responsible for the blockbuster drug Lipitor.The company is also well-known . . .

